When considering the presence of unequivocal nuclear staining in >1% of viable tumor cells (present or absent) as an additional possible risk factor, the DSF curves revealed clear significance in favor of absent nuclear staining; that is, patients presenting TGF-β nuclear staining may be more likely to relapse. This evidence concerns the gene TGFB1 and neoplasm.